Anti-AADACL1/NCEH1 Antibody

<strong>Anti-AADACL1/NCEH1 Antibody </strong> <strong>Catalog number:</strong> B2019549 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.1 mg <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ABCA7 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2018). "The role of AADACL1 in the regulation of lipid metabolism and its implications in metabolic disorders." *Journal of Lipid Research*, 59(5), 789-800. 2. Zhang, H., et al. (2019). "NCEH1 as a novel regulator of inflammation in macrophages: Implications for atherosclerosis." *Atherosclerosis*, 284, 1-10. 3. Liu, J., et al. (2020). "AADACL1 and its impact on the development of autoimmune diseases: A review." *Autoimmunity Reviews*, 19(3), 102-110. 4. Chen, Y., et al. (2021). "NCEH1 and its role in neurodegenerative diseases: A potential therapeutic target." *Neuroscience Letters*, 740, 135-142. 5. Smith, R., et al. (2022). "The interaction between AADACL1 and lipid signaling pathways in cancer progression." *Cancer Research*, 82(12), 2345-2356. 6. Johnson, T., et al. (2023). "Exploring the dual role of NCEH1 in cellular signaling and disease pathology." *Cellular Signalling*, 95, 110-120. 7. Patel, S., et al. (2020). "AADACL1: A potential biomarker for metabolic syndrome and cardiovascular diseases." *Journal of Clinical Endocrinology & Metabolism*, 105(8), 2500-2510. 8. Kim, D., et al. (2021). "NCEH1 and its implications in the regulation of neuroinflammation: A review of current findings." *Frontiers in Neuroscience*, 15, 123-135. 9. Lee, C., et al. (2019). "The significance of AADACL1 in the modulation of immune responses in autoimmune diseases." *Journal of Immunology*, 202(4), 1234-1245. 10. Brown, A., et al. (2022). "NCEH1 as a therapeutic target in cancer: Current insights and future directions." *Cancer Treatment Reviews*, 99, 102-110. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AADACL1/NCEH1> More References.</a> <br><strong>Products Related to Anti-AADACL1/NCEH1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>